Indicated for transluminal implantation in the coronary arteries or grafts derived from the aorta-coronary for the treatment of: acute perforation or rupture of the coronary arteries, aneurysms of the coronary arteries or vein bypass graft. Patients who are being considered for endoprosthesis implantation must be acceptable candidates for coronary artery bypass graft surgery. Indicated for chronic intraluminal implant in renal oilic arteries for restoration and improvement of distensibility and treatment of aneurysms and perforations, ruptures and fistulas sharp
Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.